Summary:
This study is being conducted to evaluate the safety and effectiveness of a study drug for the treatment of migraine headaches.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Experience 4 - 14 headache days within a 28 day period
•
Not have a history of chronic migraines
Qualified Participants May Receive:
Compensation for time and travel, as well as study medication, physical exams, and all tests as necessary for the completion of the study, at no cost.